BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 31874200)

  • 1. A silent agonist of α7 nicotinic acetylcholine receptors modulates inflammation ex vivo and attenuates EAE.
    Godin JR; Roy P; Quadri M; Bagdas D; Toma W; Narendrula-Kotha R; Kishta OA; Damaj MI; Horenstein NA; Papke RL; Simard AR
    Brain Behav Immun; 2020 Jul; 87():286-300. PubMed ID: 31874200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of CNS inflammatory responses by nicotine involves α7 and non-α7 nicotinic receptors.
    Hao J; Simard AR; Turner GH; Wu J; Whiteaker P; Lukas RJ; Shi FD
    Exp Neurol; 2011 Jan; 227(1):110-9. PubMed ID: 20932827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of neuroinflammation by an allosteric agonist and positive allosteric modulator of the α7 nicotinic acetylcholine receptor GAT107.
    Mizrachi T; Marsha O; Brusin K; Ben-David Y; Thakur GA; Vaknin-Dembinsky A; Treinin M; Brenner T
    J Neuroinflammation; 2021 Apr; 18(1):99. PubMed ID: 33902624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silent agonists for α7 nicotinic acetylcholine receptors.
    Papke RL; Quadri M; Gulsevin A
    Pharmacol Res; 2023 Apr; 190():106736. PubMed ID: 36940890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective alpha7 nicotinic acetylcholine receptor agonists worsen disease in experimental colitis.
    Snoek SA; Verstege MI; van der Zanden EP; Deeks N; Bulmer DC; Skynner M; Lee K; Te Velde AA; Boeckxstaens GE; de Jonge WJ
    Br J Pharmacol; 2010 May; 160(2):322-33. PubMed ID: 20423343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epibatidine induces long-term potentiation (LTP) via activation of alpha4beta2 nicotinic acetylcholine receptors (nAChRs) in vivo in the intact mouse dentate gyrus: both alpha7 and alpha4beta2 nAChRs essential to nicotinic LTP.
    Matsuyama S; Matsumoto A
    J Pharmacol Sci; 2003 Oct; 93(2):180-7. PubMed ID: 14578586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of channel activation in cognitive enhancement mediated by alpha7 nicotinic acetylcholine receptors.
    Briggs CA; Grønlien JH; Curzon P; Timmermann DB; Ween H; Thorin-Hagene K; Kerr P; Anderson DJ; Malysz J; Dyhring T; Olsen GM; Peters D; Bunnelle WH; Gopalakrishnan M
    Br J Pharmacol; 2009 Nov; 158(6):1486-94. PubMed ID: 19845675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Antinociceptive and Anti-Inflammatory Properties of the
    Quadri M; Bagdas D; Toma W; Stokes C; Horenstein NA; Damaj MI; Papke RL
    J Pharmacol Exp Ther; 2018 Nov; 367(2):203-214. PubMed ID: 30111636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The analgesic-like properties of the alpha7 nAChR silent agonist NS6740 is associated with non-conducting conformations of the receptor.
    Papke RL; Bagdas D; Kulkarni AR; Gould T; AlSharari SD; Thakur GA; Damaj MI
    Neuropharmacology; 2015 Apr; 91():34-42. PubMed ID: 25497451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory effects of α7-nicotinic ACh receptors are exerted through interactions with adenylyl cyclase-6.
    Zhu S; Huang S; Xia G; Wu J; Shen Y; Wang Y; Ostrom RS; Du A; Shen C; Xu C
    Br J Pharmacol; 2021 Jun; 178(11):2324-2338. PubMed ID: 33598912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procognitive effects of varenicline in the animal model of schizophrenia depend on α4β2- and α 7-nicotinic acetylcholine receptors.
    Potasiewicz A; Golebiowska J; Popik P; Nikiforuk A
    J Psychopharmacol; 2018 Dec; 33(1):269881118812097. PubMed ID: 30501536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of α7 positive allosteric modulators in murine inflammatory and chronic neuropathic pain models.
    Freitas K; Ghosh S; Ivy Carroll F; Lichtman AH; Imad Damaj M
    Neuropharmacology; 2013 Feb; 65():156-64. PubMed ID: 23079470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of α7 nicotinic acetylcholine receptors in regulating tumor necrosis factor-α (TNF-α) as revealed by subtype selective agonists.
    Li J; Mathieu SL; Harris R; Ji J; Anderson DJ; Malysz J; Bunnelle WH; Waring JF; Marsh KC; Murtaza A; Olson LM; Gopalakrishnan M
    J Neuroimmunol; 2011 Oct; 239(1-2):37-43. PubMed ID: 21911260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral and Molecular Basis of Cholinergic Modulation of Pain: Focus on Nicotinic Acetylcholine Receptors.
    Toma W; Ulker E; Alqasem M; AlSharari SD; McIntosh JM; Damaj MI
    Curr Top Behav Neurosci; 2020; 45():153-166. PubMed ID: 32468494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NS6740, an α7 nicotinic acetylcholine receptor silent agonist, disrupts hippocampal synaptic plasticity.
    Papke RL; Peng C; Kumar A; Stokes C
    Neurosci Lett; 2018 Jun; 677():6-13. PubMed ID: 29679680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential modulation of EAE by α9*- and β2*-nicotinic acetylcholine receptors.
    Simard AR; Gan Y; St-Pierre S; Kousari A; Patel V; Whiteaker P; Morley BJ; Lukas RJ; Shi FD
    Immunol Cell Biol; 2013 Mar; 91(3):195-200. PubMed ID: 23399696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel alpha7 nicotinic acetylcholine receptor agonist N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide improves working and recognition memory in rodents.
    Boess FG; De Vry J; Erb C; Flessner T; Hendrix M; Luithle J; Methfessel C; Riedl B; Schnizler K; van der Staay FJ; van Kampen M; Wiese WB; Koenig G
    J Pharmacol Exp Ther; 2007 May; 321(2):716-25. PubMed ID: 17308038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the Anti-inflammatory Properties of Two Nicotinic Acetylcholine Receptor Ligands, Phosphocholine and
    Richter K; Papke RL; Stokes C; Roy DC; Espinosa ES; Wolf PMK; Hecker A; Liese J; Singh VK; Padberg W; Schlüter KD; Rohde M; McIntosh JM; Morley BJ; Horenstein NA; Grau V; Simard AR
    Front Cell Neurosci; 2022; 16():779081. PubMed ID: 35431807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Counteracting desensitization of human α7-nicotinic acetylcholine receptors with bispyridinium compounds as an approach against organophosphorus poisoning.
    Scheffel C; Niessen KV; Rappenglück S; Wanner KT; Thiermann H; Worek F; Seeger T
    Toxicol Lett; 2018 Sep; 293():149-156. PubMed ID: 29248576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and electrophysiological evaluation of NS6740 derivatives: Exploration of the structure-activity relationship for alpha7 nicotinic acetylcholine receptor silent activation.
    Pismataro MC; Horenstein NA; Stokes C; Quadri M; De Amici M; Papke RL; Dallanoce C
    Eur J Med Chem; 2020 Nov; 205():112669. PubMed ID: 32810771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.